WHO ICTRP trial
The study examines the effect of two doses of intravenous dexmedetomidine on…
CTRI/2024/10/074912 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/10/074912 |
|---|---|
| Public title | The study examines the effect of two doses of intravenous dexmedetomidine on emergence agitation in pediatric patients undergoing inguinal hernia surgeries with general anesthesia using sevoflurane. It aims to determine whether dexmedetomidine can reduce agitation during recovery. |
| Scientific title | Comparison of two doses of intravenous Dexmedetomidine on emergence agitation in paediatric patients undergoing inguinal hernia surgeries under general anaesthesia with sevoflurane - Nil |
| Primary sponsor | Vmmc and SJH |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: O- Medical and Surgical |
| Interventions | Intervention1: Dexmedetomidine: 0.25µg/kg of Dexmedetomidine diluted in 5ml NaCl 0.9% over a period of 5 min Control Intervention1: Dexmedetomidine: 0.5µg/kg of Dexmedetomidine diluted in 5ml NaCl 0.9% over a period of 5 min |
| Registration date | Aug 10, 2024 |
| Target size | 62 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: